Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Dialysis Accessories Devices Market

ID: MRFR/HC/14546-HCR
128 Pages
Vikita Thakur
Last Updated: April 06, 2026

Dialysis Accessories Devices Market Research Report Information By Type (Blood Tubing Sets, Dialyzers, Peritoneal Dialysis Catheters, and Peritoneal Dialysis Transfer Sets) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Dialysis Accessories Devices Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Blood Tubing Sets
  50.     4.1.2 Dialyzers
  51.     4.1.3 Peritoneal Dialysis Catheters
  52.     4.1.4 Peritoneal Dialysis Transfer Sets
  53.   4.2 Healthcare, BY Region (USD Billion)
  54.     4.2.1 North America
  55.       4.2.1.1 US
  56.       4.2.1.2 Canada
  57.     4.2.2 Europe
  58.       4.2.2.1 Germany
  59.       4.2.2.2 UK
  60.       4.2.2.3 France
  61.       4.2.2.4 Russia
  62.       4.2.2.5 Italy
  63.       4.2.2.6 Spain
  64.       4.2.2.7 Rest of Europe
  65.     4.2.3 APAC
  66.       4.2.3.1 China
  67.       4.2.3.2 India
  68.       4.2.3.3 Japan
  69.       4.2.3.4 South Korea
  70.       4.2.3.5 Malaysia
  71.       4.2.3.6 Thailand
  72.       4.2.3.7 Indonesia
  73.       4.2.3.8 Rest of APAC
  74.     4.2.4 South America
  75.       4.2.4.1 Brazil
  76.       4.2.4.2 Mexico
  77.       4.2.4.3 Argentina
  78.       4.2.4.4 Rest of South America
  79.     4.2.5 MEA
  80.       4.2.5.1 GCC Countries
  81.       4.2.5.2 South Africa
  82.       4.2.5.3 Rest of MEA
  83. 5 SECTION V: COMPETITIVE ANALYSIS
  84.   5.1 Competitive Landscape
  85.     5.1.1 Overview
  86.     5.1.2 Competitive Analysis
  87.     5.1.3 Market share Analysis
  88.     5.1.4 Major Growth Strategy in the Healthcare
  89.     5.1.5 Competitive Benchmarking
  90.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  91.     5.1.7 Key developments and growth strategies
  92.       5.1.7.1 New Product Launch/Service Deployment
  93.       5.1.7.2 Merger & Acquisitions
  94.       5.1.7.3 Joint Ventures
  95.     5.1.8 Major Players Financial Matrix
  96.       5.1.8.1 Sales and Operating Income
  97.       5.1.8.2 Major Players R&D Expenditure. 2023
  98.   5.2 Company Profiles
  99.     5.2.1 Fresenius Medical Care (DE)
  100.       5.2.1.1 Financial Overview
  101.       5.2.1.2 Products Offered
  102.       5.2.1.3 Key Developments
  103.       5.2.1.4 SWOT Analysis
  104.       5.2.1.5 Key Strategies
  105.     5.2.2 Baxter International (US)
  106.       5.2.2.1 Financial Overview
  107.       5.2.2.2 Products Offered
  108.       5.2.2.3 Key Developments
  109.       5.2.2.4 SWOT Analysis
  110.       5.2.2.5 Key Strategies
  111.     5.2.3 DaVita Inc. (US)
  112.       5.2.3.1 Financial Overview
  113.       5.2.3.2 Products Offered
  114.       5.2.3.3 Key Developments
  115.       5.2.3.4 SWOT Analysis
  116.       5.2.3.5 Key Strategies
  117.     5.2.4 Nipro Corporation (JP)
  118.       5.2.4.1 Financial Overview
  119.       5.2.4.2 Products Offered
  120.       5.2.4.3 Key Developments
  121.       5.2.4.4 SWOT Analysis
  122.       5.2.4.5 Key Strategies
  123.     5.2.5 Medtronic (US)
  124.       5.2.5.1 Financial Overview
  125.       5.2.5.2 Products Offered
  126.       5.2.5.3 Key Developments
  127.       5.2.5.4 SWOT Analysis
  128.       5.2.5.5 Key Strategies
  129.     5.2.6 Asahi Kasei Medical (JP)
  130.       5.2.6.1 Financial Overview
  131.       5.2.6.2 Products Offered
  132.       5.2.6.3 Key Developments
  133.       5.2.6.4 SWOT Analysis
  134.       5.2.6.5 Key Strategies
  135.     5.2.7 Dialife S.A. (CH)
  136.       5.2.7.1 Financial Overview
  137.       5.2.7.2 Products Offered
  138.       5.2.7.3 Key Developments
  139.       5.2.7.4 SWOT Analysis
  140.       5.2.7.5 Key Strategies
  141.     5.2.8 Kawasumi Laboratories (JP)
  142.       5.2.8.1 Financial Overview
  143.       5.2.8.2 Products Offered
  144.       5.2.8.3 Key Developments
  145.       5.2.8.4 SWOT Analysis
  146.       5.2.8.5 Key Strategies
  147.     5.2.9 Gambro (SE)
  148.       5.2.9.1 Financial Overview
  149.       5.2.9.2 Products Offered
  150.       5.2.9.3 Key Developments
  151.       5.2.9.4 SWOT Analysis
  152.       5.2.9.5 Key Strategies
  153.     5.2.10 Terumo Corporation (JP)
  154.       5.2.10.1 Financial Overview
  155.       5.2.10.2 Products Offered
  156.       5.2.10.3 Key Developments
  157.       5.2.10.4 SWOT Analysis
  158.       5.2.10.5 Key Strategies
  159.   5.3 Appendix
  160.     5.3.1 References
  161.     5.3.2 Related Reports
  162. 6 LIST OF FIGURES
  163.   6.1 MARKET SYNOPSIS
  164.   6.2 NORTH AMERICA MARKET ANALYSIS
  165.   6.3 US MARKET ANALYSIS BY TYPE
  166.   6.4 CANADA MARKET ANALYSIS BY TYPE
  167.   6.5 EUROPE MARKET ANALYSIS
  168.   6.6 GERMANY MARKET ANALYSIS BY TYPE
  169.   6.7 UK MARKET ANALYSIS BY TYPE
  170.   6.8 FRANCE MARKET ANALYSIS BY TYPE
  171.   6.9 RUSSIA MARKET ANALYSIS BY TYPE
  172.   6.10 ITALY MARKET ANALYSIS BY TYPE
  173.   6.11 SPAIN MARKET ANALYSIS BY TYPE
  174.   6.12 REST OF EUROPE MARKET ANALYSIS BY TYPE
  175.   6.13 APAC MARKET ANALYSIS
  176.   6.14 CHINA MARKET ANALYSIS BY TYPE
  177.   6.15 INDIA MARKET ANALYSIS BY TYPE
  178.   6.16 JAPAN MARKET ANALYSIS BY TYPE
  179.   6.17 SOUTH KOREA MARKET ANALYSIS BY TYPE
  180.   6.18 MALAYSIA MARKET ANALYSIS BY TYPE
  181.   6.19 THAILAND MARKET ANALYSIS BY TYPE
  182.   6.20 INDONESIA MARKET ANALYSIS BY TYPE
  183.   6.21 REST OF APAC MARKET ANALYSIS BY TYPE
  184.   6.22 SOUTH AMERICA MARKET ANALYSIS
  185.   6.23 BRAZIL MARKET ANALYSIS BY TYPE
  186.   6.24 MEXICO MARKET ANALYSIS BY TYPE
  187.   6.25 ARGENTINA MARKET ANALYSIS BY TYPE
  188.   6.26 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  189.   6.27 MEA MARKET ANALYSIS
  190.   6.28 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  191.   6.29 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  192.   6.30 REST OF MEA MARKET ANALYSIS BY TYPE
  193.   6.31 KEY BUYING CRITERIA OF HEALTHCARE
  194.   6.32 RESEARCH PROCESS OF MRFR
  195.   6.33 DRO ANALYSIS OF HEALTHCARE
  196.   6.34 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  197.   6.35 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  198.   6.36 SUPPLY / VALUE CHAIN: HEALTHCARE
  199.   6.37 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  200.   6.38 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  201.   6.39 BENCHMARKING OF MAJOR COMPETITORS
  202. 7 LIST OF TABLES
  203.   7.1 LIST OF ASSUMPTIONS
  204.     7.1.1
  205.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  206.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  207.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  208.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  209.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  210.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  211.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  212.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  213.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  214.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  215.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  216.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  217.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  218.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  219.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  220.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  221.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  222.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  223.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  224.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  225.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  226.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  227.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  228.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  229.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  230.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  231.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  232.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  233.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  234.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  235.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  236.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  237.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  238.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  239.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  240.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  241.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  242.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  243.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  244.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  245.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  246.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  247.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  248.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  249.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  250.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  251.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  252.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  253.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  254.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  255.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  256.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  257.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  258.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  259.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  260.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  261.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  262.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  263.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  264.     7.31.1
  265.   7.32 ACQUISITION/PARTNERSHIP
  266.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Blood Tubing Sets
  • Dialyzers
  • Peritoneal Dialysis Catheters
  • Peritoneal Dialysis Transfer Sets

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions